Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Torchlight Energy Is Now Meta Materials, but Its Outlook Isn’t Any Better

By Ian Bezek, InvestorPlace Contributor
TRCH stock turned into MMAT stock recently when Torchlight merged with Meta Materials. But there's still little to justify an investment.

Now Meta Materials, TRCH Is Just Another Meme with Plenty of Risks

By Stavros Georgiadis, CFA, InvestorPlace Contributor
TRCH stock just saw a reverse split and a business combination, but the meme trade here is just one of many reasons to avoid the new stock.

SoFi Is a Fundamentally Weak Ticking Time Bomb

By Alex Sirois, InvestorPlace Contributor
SOFI stock is not an equity that investors should have in their portfolios now, and it'll likely soon be getting worse.

7 Meme Stocks That You Shouldn’t Touch With a 10-Foot Pole

By Chris Markoch, InvestorPlace Contributor
Not all meme stocks are "bad." But with retail investors beginning to realize the heavy lift that awaits them, you should avoid these seven.

Sell or Short DiDi Global Stock as China’s Crackdown on Big Tech Continues

By Larry Ramer, InvestorPlace Contributor
There's a good chance that the Chinese government will cripple Didi, making DIDI stock a definite sell at this point.

10 Stocks to Sell Before They Crash and Burn 

By Will Ashworth, InvestorPlace Contributor
Most of the names on this list of stocks to sell are companies with a good future. Their valuations have just gotten ahead of themselves.

Don’t Create Problems for Your Portfolio with Creatd

By Louis Navellier and the InvestorPlace Research Staff
The poor performance of CRTD stock, along with a bleak fiscal picture for the company, add up to a highly unfavorable risk-to-reward profile.

7 Overvalued Stocks to Sell Now Ahead of a Potential Correction

By Ian Bezek, InvestorPlace Contributor
The recent drop was a good reminder that risk happens fast. These seven stocks to sell are overvalued and could slump in the next correction.

6 Homebuilder Stocks to Avoid While the Real Estate Market Runs Hot

By Louis Navellier and the InvestorPlace Research Staff
The housing market may be booming but that doesn't mean all homebuilders are experiencing the same types of success.

Novavax Stock May Not Get the Delta Varient Bump Investors Need

By Josh Enomoto, InvestorPlace Contributor
While NVAX stock may enjoy increased relevance on paper due to the delta variant, investors should think about the bigger picture.

Weak Fundamentals Prove There Is No Reason to Buy Bionano Genomics

By Stavros Georgiadis, CFA, InvestorPlace Contributor
Bionano Genomics is risky and its valuation does not justify its price. There is no compelling argument for a buy in BNGO stock.

If You Bet on Workhorse, You’re Walking on Your Own

By Josh Enomoto, InvestorPlace Contributor
WKHS stock may have been a high-potential trade but without the USPS contract, it might meander aimlessly for a while.

Krispy Kreme Stock Should Drop 40% To $9.65 Before It Looks Reasonable

By Mark R. Hake, CFA
Krispy Kreme paid off a significant chunk of debt by going public, which we can use to calculate the actual value of DNUT stock.

Blackberry’s Time Has Passed. Stay Away From BB Stock.

By Joel Baglole, InvestorPlace Contributor
The one-time giant of the tech world likes to say it is more than a meme stock, but its finances and outlook say otherwise. Avoid BB stock.

7 Popular China Stocks to Avoid Until Further Notice

By Josh Enomoto, InvestorPlace Contributor
While China stocks have performed well over the last several years, recent headwinds suggest caution is in order.

AMC Stock Faces a Day of Reckoning as Its Debt Load Multiplies

By Will Ashworth, InvestorPlace Contributor
AMC has $11.05 billion in total debt. Could it pass a stress test? That’s an answer investors ought to get before buying AMC stock. 

Ocugen Likely Can’t Get a Boost From the FDA Until 2023

By Larry Ramer, InvestorPlace Contributor
It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete. Sell OCGN stock.

Clover Health Hasn’t Lived Up to Its Billing as a Healthcare Disruptor

By Muslim Farooque, InvestorPlace Contributor
CLOV stock has no competitive moat at this point, as its software has failed to garner traction among healthcare providers.

It’s Holding Up Now, But Gamestop Stock Could Still Tumble

By Thomas Niel, InvestorPlace Contributor
GME stock has been resilient compared to other Reddit plays, but don't take that to mean it's immune from future declines.
Load More Articles